Immunic (IMUX) Non-Current Assets (2013 - 2026)
Immunic (IMUX) posted Non-Current Assets of $983000.0 for Q1 2026, down 16.91% sequentially from $1.2 million in Q4 2025, and down 36.17% YoY from $1.5 million in Q1 2025.
Immunic (IMUX) Non-Current Assets (2013 - 2026) Analysis & Trends
Immunic has reported Non-Current Assets for 14 years, with the latest figure at $983000.0 in Q1 2026.
- Quarterly Non-Current Assets fell 36.17% year-over-year to $983000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $5.2 million (down 14.81% YoY) and the FY2025 annual result came in at $1.2 million, down 22.98% from the prior year.
- Non-Current Assets slipped to $983000.0 in Q1 2026 per IMUX's latest filing, from $1.2 million in the prior quarter.
- Over five years, Non-Current Assets peaked at $34.4 million in Q3 2022 and troughed at $983000.0 in Q1 2026.
- A 5-year average of $7.4 million and a median of $1.6 million in 2025 frame the typical range for Non-Current Assets.
- The sharpest annual moves came in 2023 and 2025: Non-Current Assets sank 94.94% in 2023, then rose 4.89% in 2025.
- Over 5 years, Non-Current Assets stood at $1.9 million in 2022, then retreated by 6.56% to $1.8 million in 2023, then dropped by 12.97% to $1.5 million in 2024, then retreated by 22.98% to $1.2 million in 2025, then retreated by 16.91% to $983000.0 in 2026.
- According to Business Quant data, Non-Current Assets over the past three periods registered $983000.0, $1.2 million, and $1.4 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 14.88 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 23.28 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 1.96 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 294.93 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 1.96 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 3.76 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 18.06 Bn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 938.60 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 468.65 Mn |
| 10 | Immunic | 682.77 Mn | 682.77 Mn | - | 1.34 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.34 Mn |
| Mar 31, 2026 | 983,000.00 |
| Dec 31, 2025 | 1.18 Mn |
| Sep 30, 2025 | 1.43 Mn |
| Jun 30, 2025 | 1.59 Mn |
| Mar 31, 2025 | 1.54 Mn |
| Dec 31, 2024 | 1.54 Mn |
| Sep 30, 2024 | 1.50 Mn |
| Jun 30, 2024 | 1.51 Mn |
| Mar 31, 2024 | 1.54 Mn |
| Dec 31, 2023 | 1.77 Mn |
| Sep 30, 2023 | 1.74 Mn |
| Jun 30, 2023 | 2.19 Mn |
| Mar 31, 2023 | 2.29 Mn |
| Dec 31, 2022 | 1.89 Mn |
| Sep 30, 2022 | 34.43 Mn |
| Jun 30, 2022 | 33.90 Mn |
| Mar 31, 2022 | 34.04 Mn |
| Dec 31, 2021 | 34.11 Mn |
| Sep 30, 2021 | 34.26 Mn |